Drug Enforcement D-600-2013

Marketed Without an Approved NDA/ANDA: product contains sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.

Status

Terminated

Classification

Class I

Report Date

June 19, 2013

Termination Date

October 1, 2019

Product Information

Product description
MAXILOSS Weight Advanced, 225 mg proprietary blend of herbs, supplied in 36 count capsules in Green & Blue Boxes, Formulated and distributed by Olaax Corp, Lakeland, FL
Product quantity
600 boxes
Reason for recall
Marketed Without an Approved NDA/ANDA: product contains sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.
Recall initiation reason
Initial firm notification
Telephone
Distribution pattern
Nationwide, Puerto Rico and Venezuela and Bolivia

Location & Firm

Recalling firm
OLAAX International
Address
6105 Riverlake Blvd, N/A

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-600-2013
Event ID
64409
Recall initiation date
February 12, 2013
Center classification date
June 13, 2013
Code info
All Lots
More code info